Home » Reports » Broker Ratings » GlaxoSmithKline plc 2.3% Potential Decrease Indicated by Deutsche Bank
broker ratings

GlaxoSmithKline plc 2.3% Potential Decrease Indicated by Deutsche Bank

GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘HOLD’ today by analysts at Deutsche Bank. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set a target price of 1525 GBX on its stock. This is indicating the analyst believes there is a potential downside of -2.3% from today’s opening price of 1561.2 GBX. Over the last 30 and 90 trading days the company share price has increased 11.2 points and increased 128.2 points respectively. The 1 year high stock price is 1632 GBX while the year low share price is currently 1179.39 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,537.95 GBX and a 200 Day Moving Average share price is recorded at 1,410.18. There are currently 4,959,866,880 shares in issue with the average daily volume traded being 9,623,406. Market capitalisation for LON:GSK is £77,253,745,899 GBP.